Results 271 to 280 of about 325,932 (347)

Relationships of Isolated Nocturnal Hypertension with Glomerular Filtration Rate and Albuminuria. [PDF]

Diseases
Carollo C, Geraci G, Sorce A, Morreale Bubella R, Cirafici E, Ciuppa ME, Evola S, Mulè G.   +7 more
europepmc   +1 more source

Variations in Estimated Glomerular Filtration Rate Across Countries in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease and Their Association With Liver Fibrosis: A Multicenter Study. [PDF]

MedComm (2020)
Zhao J, Mózes FE, Xu XY, Ji D, Liang H, Chi X, Chen J, Okanoue T, Shima T, Zhu Y, Labenz C, Zhong B, Yoneda M, Nakajima A, Shi J, Zhang J, Mahadeva S, Chan WK, He F, Ye CY, Lin S, Delamarre A, de Lédinghen V, Lupsor-Platon M, Lu Z, Tang H, Jia J, Eddowes PJ, Xu L, Li Y, Nan Y, Deng H, Niu J, Yan X, Ye Q, Zeng Q, Zhou Y, Cobbold JFL, Liu C, Li J, Li L, Wang J, Ji F, Chai J, Xin Y, Targher G, Byrne CD, Fan Y, Zhang JH, Ooi G, George J, Pavlides M, Sun DQ, Zheng MH.   +53 more
europepmc   +1 more source

Two causes of COVID‐19‐related myocardial injury‐associated cardiogenic shock: Myocarditis and microvascular thrombosis

ESC Heart Failure, Volume 12, Issue 2, Page 1514-1522, April 2025.
Takamasa Iwai, Hirohiko Aikawa, Yoshiaki Morita, Keiko Ohta‐Ogo, Teruo Noguchi   +4 more
wiley   +1 more source

SPARCL1 and NT‐proBNP as biomarkers of right ventricular‐to‐pulmonary artery uncoupling in pulmonary hypertension

ESC Heart Failure, Volume 12, Issue 2, Page 1416-1426, April 2025.
Abstract Aims SPARCL1 was recently identified as a biomarker of right ventricular (RV) maladaptation in patients with pulmonary hypertension (PH), and N‐terminal pro‐brain natriuretic protein (NT‐proBNP) is an established biomarker of RV failure in PH. The present study investigated whether NT‐proBNP and SPARCL1 concentrations are associated with load ...
Oliver Dörr, Stanislav Keranov, Paulina van Wickern, Holger Nef, Christian Hamm, Pascal Bauer, Christian Troidl, Samuel Sossalla, Sandra Voss, Christoph Liebetrau, Manuel J. Richter, Henning Gall, Werner Seeger, Ardeschir Ghofrani, Athiththan Yogeswaran, Khodr Tello   +15 more
wiley   +1 more source

Three months of bempedoic acid treatment does not affect cystatin C-based estimation of glomerular filtration rate. [PDF]

High Blood Press Cardiovasc Prev
Serio L, Paolucci A, Carugno ME, Cappannari S, Cecchini A, Litterio M, Del Pinto R, Ferri C.   +7 more
europepmc   +1 more source

Cilostazol in patients with heart failure and preserved ejection fraction—The CLIP‐HFpEF trial

ESC Heart Failure, Volume 12, Issue 2, Page 1437-1446, April 2025.
• Cilostazol is an oral PDE‐3 inhibitor that may have advantageous effects in heart failure with preserved ejection fraction (HFpEF). • Cilostazol significantly improved short‐term heart failure‐related health status scores (KCCQ‐12) and NT‐proBNP levels when compared to placebo.
Norman Aiad, Jeanne du Fay de Lavallaz, Michael J. Zhang, Thanat Chaikijurajai, Bo Ye, Prabhjot S. Nijjar, Julie A. Lahiri, Cindy M. Martin, Tamas Alexy, Markus Meyer   +9 more
wiley   +1 more source

Current Status of Standardization of Glomerular Filtration Rate Markers in Korea. [PDF]

Ann Lab Med
Jeong TD.
europepmc   +1 more source

Real-world analysis of the impact of finerenone on estimated glomerular filtration rate and albuminuria in patients with diabetic kidney disease. [PDF]

Clin Kidney J
Ichijo K, Yamaguchi R, Takashima H, Kobayashi H, Maruyama T, Abe M.   +5 more
europepmc   +1 more source

Influence of the estimated glomerular filtration rate equation on carboplatin dosing: a real-world study. [PDF]

Front Pharmacol
Fortunato AR, Barbosa C, Araujo A, Fernandez-Llimos F.   +3 more
europepmc   +1 more source

Association Between Thyroid-Stimulating Hormone and Estimated Glomerular Filtration Rate in the Third Trimester of Pregnancy: A Retrospective Cross-Sectional Study in Euthyroid Women. [PDF]

Medicina (Kaunas)
Satır Özel C, Sertbaş Y, Taştekin Ş, Tancer Özçelik A, Sertbaş M, Kınlı Yıldız Ö, Turgut A.   +6 more
europepmc   +1 more source